01 — At a Glance
From Rainbow Dyes to Copper Dreams: The Ultimate Pivot Story
- Q3 FY26 Consolidated PAT₹4,881 Cr
- Core Operating PAT (Q3)-₹14 Cr
- Exceptional Gain (DyStar)₹5,854 Cr
- Consolidated Revenue (Q3)₹174 Cr
- 9M FY26 Revenue Growth+10% YoY
- DyStar Proceeds Received₹6,195 Cr
- Copper Capex Planned₹13,300 Cr
- Book Value Per Share₹546
- Stock Return (1 Year)-38.6%
- Promoter Holding36.7%
Flash Summary: Kiri Industries just won an 11-year lawsuit and got handed ₹6,195 crore in DyStar proceeds. The core business is bleeding red. So management did what any sensible company would do — announced a ₹13,300 crore bet on copper smelting. The stock crashed 36% in 6 months. Welcome to India Inc in 2026: dyes yesterday, copper tomorrow, shareholder patience always.
02 — Introduction
The Dye Company That Won a Lottery Ticket and Decided to Mine Metals
Kiri Industries Limited is one of India’s top exporters of dyes, dye intermediates, and basic chemicals. Established in 1998, it’s been supplying colors to textile factories across 50+ countries, making a few crores here and there. Nice business. Boring business. Profitable eventually. But not exciting enough apparently.
In 2010, Kiri made an investment in DyStar Global Holdings — a Singapore-listed dye company. For 15 years, the investment lived in the balance sheet collecting dust and delivering dividends. But in 2015, Kiri filed a minority oppression lawsuit against DyStar’s majority shareholder, alleging oppressive conduct. The Singapore International Commercial Court (SICC) said: “Yes, you’re right. We’re going to order a buyout.” Then came 10 years of appeals, counter-appeals, and enough legal drama to fill a Bollywood script.
On December 31, 2025, the money finally arrived: ₹6,195 crore. And Kiri Industries looked at this windfall and said: “You know what? Let’s pivot to copper smelting. And fertilizers. And precious metal refining. All at once. Across an entirely new business.” Enter Indo Asia Copper Limited, the ₹13,300 crore greenfield mega-project that will make Kiri either a manufacturing powerhouse or a cautionary tale about over-leveraged pivots. Time will tell.
Concall Insight (Feb 2026): Management was unusually direct about capital allocation. When asked about dividends, the Board said “refrain from asking” and that the decision is “final and firm.” Translation: All the cash is going into copper. The dye business? It’s still there, still paying employees, still losing market share to Chinese dumping, still watching the currency wobble. But it’s not getting fresh capital anytime soon.
03 — Business Model: From Textiles to Truck Batteries
When Your Core Business is Dying but Your Legal Team Just Inherited Billions
Kiri’s original business is vertically integrated dye production. You take sulphur, turn it into basic chemicals (Sulphuric Acid, Oleum, Chloro Sulphonic Acid). Then you transform those into dye intermediates (H-Acid, Vinyl Sulphone). Finally, you manufacture finished dyes (Reactive, Acid, Disperse) and ship them globally to textile factories. It’s simple. It’s profitable when demand is strong. It’s a nightmare when China starts exporting at cost-plus-10%.
Revenue breakdown in 9M FY26: Dye Intermediates 52%, Dyes 34%, Basic Chemicals 14%. The company has 5 manufacturing units across Ahmedabad and Vadodara, with 300+ thousand metric tonnes per annum of capacity. They’ve served clients on 7 continents and maintained 56% domestic, 44% export revenue split.
But here’s the problem: global demand for dyes crashed post-2022. US tariffs on Indian dyes jumped sharply in 2025 (then eased slightly in Feb 2026 via a new trade framework). Chinese competitors dumped at below-cost prices. The industry faced environmental crackdowns that forced consolidation. By FY25, Kiri’s consolidated revenue was ₹740 crore — down from ₹1,497 crore in FY22. That’s a 51% collapse in three years.
So Kiri did what visionary companies do: they decided to stop making dyes. Sort of. They kept the plants running (EBITDA was -₹437 crore in FY25), collected dividends from their JV with China’s Longsheng Group, and then bet the entire company on a sector they have zero experience in.
Dye Intermediates52%of revenue
Dyes34%of revenue
Basic Chemicals14%of revenue
Countries Served50+across continents
04 — Financials Overview
Q3 FY26: When ₹6K Crore Masks ₹0 Operating Profit
Result type: Quarterly Results | Q3 FY26 Consolidated EPS: ₹824.52 | TTM EPS: ₹826.56 | Annualised Q3 EPS (× 4): ₹3,298.08
| Metric (₹ Mn) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 174 | 179 | 213 | -2.8% | -18.3% |
| EBITDA | -49 | -44 | -14 | +11% | -250% |
| EBITDA Margin % | -28% | -25% | -6% | -300 bps | -2200 bps |
| PAT (Core) | -14 | -44 | -5 | +68% | -180% |
| Exceptional Gain | 5,854 | 0 | 0 | ∞ | ∞ |
| Reported PAT | 4,881 | -14 | 20 | +35,764% | +24,305% |
What Just Happened: Strip away the DyStar exceptional gain, and Kiri’s Q3 core PAT was -₹14 crore. Revenue fell 2.8% YoY and 18.3% QoQ. EBITDA margin hit -28%, down from -25% a year ago. The dye business is deteriorating. But reported PAT of ₹4,881 crore looks like a rocket because one line item — the DyStar lawsuit settlement — was worth ₹5,854 crore. This is what happens when you confuse windfalls with earnings power.
💬 If Kiri’s core dye business is declining 3% YoY with negative EBITDA, and they’re about to spend ₹13,300 crore on a new business, is this bold visionary capital allocation or a desperate Hail Mary by a struggling company? What’s your read?
05 — Valuation: The Windfall Lottery
Book Value ₹546, Stock Price ₹363. Why Is The Market Selling at 33% Discount?
